{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:28:56Z","timestamp":1785821336053,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T00:00:00Z","timestamp":1412208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T00:00:00Z","timestamp":1412208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1038\/gt.2014.87","type":"journal-article","created":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T10:17:55Z","timestamp":1412245075000},"page":"1051-1057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Rapid outer-surface protein C DNA tattoo vaccination protects against Borrelia afzelii infection"],"prefix":"10.1038","volume":"21","author":[{"given":"A","family":"Wagemakers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M K","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Oei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"de Wever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"van der Poll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A D","family":"Bins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J W R","family":"Hovius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,2]]},"reference":[{"key":"BFgt201487_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1469-0691.2011.03492.x","volume":"17","author":"G Stanek","year":"2011","unstructured":"Stanek G, Reiter M . The expanding Lyme Borrelia complex\u2014clinical significance of genomic species?. Clin Microbiol Infect 2011; 17: 487\u2013493.","journal-title":"Clin Microbiol Infect"},{"key":"BFgt201487_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","volume":"379","author":"G Stanek","year":"2012","unstructured":"Stanek G, Wormser GP, Gray J, Strle F . Lyme borreliosis. Lancet 2012; 379: 461\u2013473.","journal-title":"Lancet"},{"key":"BFgt201487_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nrmicro2714","volume":"10","author":"JD Radolf","year":"2012","unstructured":"Radolf JD, Caimano MJ, Stevenson B, Hu LT . Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol 2012; 10: 87\u201399.","journal-title":"Nat Rev Microbiol"},{"key":"BFgt201487_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1172\/JCI200419894","volume":"113","author":"U Pal","year":"2004","unstructured":"Pal U, Yang X, Chen M, Bockenstedt LK, Anderson JF, Flavell RA et al. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J Clin Invest 2004; 113: 220\u2013230.","journal-title":"J Clin Invest"},{"key":"BFgt201487_CR5","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1073\/pnas.0306845101","volume":"101","author":"D Grimm","year":"2004","unstructured":"Grimm D, Tilly K, Byram R, Stewart PE, Krum JG, Bueschel DM et al. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc Natl Acad Sci USA 2004; 101: 3142\u20133147.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201487_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nature03812","volume":"436","author":"N Ramamoorthi","year":"2005","unstructured":"Ramamoorthi N, Narasimhan S, Pal U, Bao F, Yang XF, Fish D et al. The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 2005; 436: 573\u2013577.","journal-title":"Nature"},{"key":"BFgt201487_CR7","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1086\/591917","volume":"198","author":"JW Hovius","year":"2008","unstructured":"Hovius JW, Schuijt TJ, de Groot KA, Roelofs JJ, Oei GA, Marquart JA et al. Preferential protection of Borrelia burgdorferi sensu stricto by a Salp15 homologue in Ixodes ricinus saliva. J Infect Dis 2008; 198: 1189\u20131197.","journal-title":"J Infect Dis"},{"key":"BFgt201487_CR8","doi-asserted-by":"publisher","first-page":"s253","DOI":"10.1093\/cid\/ciq116","volume":"52","author":"GA Poland","year":"2011","unstructured":"Poland GA . Vaccines against Lyme disease: what happened and what lessons can we learn?. Clin Infect Dis 2011; 52: s253\u2013s258.","journal-title":"Clin Infect Dis"},{"key":"BFgt201487_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pt.2010.06.006","volume":"27","author":"TJ Schuijt","year":"2011","unstructured":"Schuijt TJ, Hovius JW, van der Poll T, van Dam AP, Fikrig E . Lyme borreliosis vaccination: the facts, the challenge, the future. Trends Parasitol 2011; 27: 40\u201347.","journal-title":"Trends Parasitol"},{"key":"BFgt201487_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/infdis\/175.1.91","volume":"175","author":"CJ Luke","year":"1997","unstructured":"Luke CJ, Carner K, Liang X, Barbour AG . An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. J Infect Dis 1997; 175: 91\u201397.","journal-title":"J Infect Dis"},{"key":"BFgt201487_CR11","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1286-4579(03)00182-5","volume":"5","author":"S Scheiblhofer","year":"2003","unstructured":"Scheiblhofer S, Weiss R, Durnberger H, Mostbock S, Breitenbach M, Livey I et al. A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses. Microbes Infect 2003; 5: 939\u2013946.","journal-title":"Microbes Infect"},{"key":"BFgt201487_CR12","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0264-410X(99)00338-2","volume":"18","author":"R Weiss","year":"1999","unstructured":"Weiss R, Durnberger J, Mostbock S, Scheiblhofer S, Hartl A, Breitenbach M et al. Improvement of the immune response against plasmid DNA encoding OspC of Borrelia by an ER-targeting leader sequence. Vaccine 1999; 18: 815\u2013824.","journal-title":"Vaccine"},{"key":"BFgt201487_CR13","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1016\/S0264-410X(02)00250-5","volume":"20","author":"R Weiss","year":"2002","unstructured":"Weiss R, Scheiblhofer S, Freund J, Ferreira F, Livey I, Thalhamer J . Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine 2002; 20: 3148\u20133154.","journal-title":"Vaccine"},{"key":"BFgt201487_CR14","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nm1264","volume":"11","author":"AD Bins","year":"2005","unstructured":"Bins AD, Jorritsma A, Wolkers MC, Hung CF, Wu TC, Schumacher TN et al. A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med 2005; 11: 899\u2013904.","journal-title":"Nat Med"},{"key":"BFgt201487_CR15","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<946::AID-IMMU946>3.0.CO;2-P","volume":"29","author":"W Zhong","year":"1999","unstructured":"Zhong W, Gern L, Stehle T, Museteanu C, Kramer M, Wallich R et al. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC. Eur J Immunol 1999; 29: 946\u2013957.","journal-title":"Eur J Immunol"},{"key":"BFgt201487_CR16","doi-asserted-by":"publisher","first-page":"12533","DOI":"10.1073\/pnas.94.23.12533","volume":"94","author":"W Zhong","year":"1997","unstructured":"Zhong W, Stehle T, Museteanu C, Siebers A, Gern L, Kramer M et al. Therapeutic passive vaccination against chronic Lyme disease in mice. Proc Natl Acad Sci USA 1997; 94: 12533\u201312538.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201487_CR17","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1002\/j.1460-2075.1988.tb03037.x","volume":"7","author":"JL Dangl","year":"1988","unstructured":"Dangl JL, Wensel TG, Morrison SL, Stryer L, Herzenberg LA, Oi VT . Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J 1988; 7: 1989\u20131994.","journal-title":"EMBO J"},{"key":"BFgt201487_CR18","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1016\/j.vaccine.2006.12.051","volume":"25","author":"CG Earnhart","year":"2007","unstructured":"Earnhart CG, Marconi RT . Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens. Vaccine 2007; 25: 3419\u20133427.","journal-title":"Vaccine"},{"key":"BFgt201487_CR19","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.4049\/jimmunol.155.4.2020","volume":"155","author":"A Keane-Myers","year":"1995","unstructured":"Keane-Myers A, Nickell SP . Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. J Immunol 1995; 155: 2020\u20132028.","journal-title":"J Immunol"},{"key":"BFgt201487_CR20","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1084\/jem.181.3.1251","volume":"181","author":"JE Matyniak","year":"1995","unstructured":"Matyniak JE, Reiner SL . T helper phenotype and genetic susceptibility in experimental Lyme disease. J Exp Med 1995; 181: 1251\u20131254.","journal-title":"J Exp Med"},{"key":"BFgt201487_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/infdis\/173.1.187","volume":"173","author":"N Zeidner","year":"1996","unstructured":"Zeidner N, Dreitz M, Belasco D, Fish D . Suppression of acute Ixodes scapularis-induced Borrelia burgdorferi infection using tumor necrosis factor-alpha, interleukin-2, and interferon-gamma. J Infect Dis 1996; 173: 187\u2013195.","journal-title":"J Infect Dis"},{"key":"BFgt201487_CR22","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.1128\/IAI.73.12.7869-7877.2005","volume":"73","author":"CG Earnhart","year":"2005","unstructured":"Earnhart CG, Buckles EL, Dumler JS, Marconi RT . Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response. Infect Immun 2005; 73: 7869\u20137877.","journal-title":"Infect Immun"},{"key":"BFgt201487_CR23","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1128\/CVI.00409-06","volume":"14","author":"CG Earnhart","year":"2007","unstructured":"Earnhart CG, Marconi RT . OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine. Clin Vaccine Immunol 2007; 14: 628\u2013634.","journal-title":"Clin Vaccine Immunol"},{"key":"BFgt201487_CR24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/genetics\/151.1.15","volume":"151","author":"IN Wang","year":"1999","unstructured":"Wang IN, Dykhuizen DE, Qiu W, Dunn JJ, Bosler EM, Luft BJ . Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics 1999; 151: 15\u201330.","journal-title":"Genetics"},{"key":"BFgt201487_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/infdis\/175.2.400","volume":"175","author":"WS Probert","year":"1997","unstructured":"Probert WS, Crawford M, Cadiz RB, LeFebvre RB . Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi. J Infect Dis 1997; 175: 400\u2013405.","journal-title":"J Infect Dis"},{"key":"BFgt201487_CR26","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1038\/jid.2009.202","volume":"129","author":"JW Hovius","year":"2009","unstructured":"Hovius JW . Spitting image: tick saliva assists the causative agent of Lyme disease in evading host skin's innate immune response. J Invest Dermatol 2009; 129: 2337\u20132339.","journal-title":"J Invest Dermatol"},{"key":"BFgt201487_CR27","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1128\/IAI.00521-12","volume":"80","author":"A Bestor","year":"2012","unstructured":"Bestor A, Rego RO, Tilly K, Rosa PA . Competitive advantage of Borrelia burgdorferi with outer surface protein BBA03 during tick-mediated infection of the mammalian host. Infect Immun 2012; 80: 3501\u20133511.","journal-title":"Infect Immun"},{"key":"BFgt201487_CR28","doi-asserted-by":"publisher","first-page":"e1003567","DOI":"10.1371\/journal.ppat.1003567","volume":"9","author":"TC Ellis","year":"2013","unstructured":"Ellis TC, Jain S, Linowski AK, Rike K, Bestor A, Rosa PA et al. In vivo expression technology identifies a novel virulence factor critical for Borrelia burgdorferi persistence in mice. PLoS Pathog 2013; 9: e1003567.","journal-title":"PLoS Pathog"},{"key":"BFgt201487_CR29","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/iai.64.6.2234-2239.1996","volume":"64","author":"RD Gilmore Jr","year":"1996","unstructured":"Gilmore RD Jr, Kappel KJ, Dolan MC, Burkot TR, Johnson BJ . Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC. Infect Immun 1996; 64: 2234\u20132239.","journal-title":"Infect Immun"},{"key":"BFgt201487_CR30","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1128\/IAI.67.10.5470-5472.1999","volume":"67","author":"ML Mbow","year":"1999","unstructured":"Mbow ML, Gilmore Jr RD, Titus RG . An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31. Infect Immun 1999; 67: 5470\u20135472.","journal-title":"Infect Immun"},{"key":"BFgt201487_CR31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1128\/IAI.68.1.411-414.2000","volume":"68","author":"Jr Gilmore RD","year":"2000","unstructured":"Gilmore Jr RD, Piesman J . Inhibition of Borrelia burgdorferi migration from the midgut to the salivary glands following feeding by ticks on OspC-immunized mice. Infect Immun 2000; 68: 411\u2013414.","journal-title":"Infect Immun"},{"key":"BFgt201487_CR32","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1016\/j.vaccine.2008.03.091","volume":"26","author":"BE Verstrepen","year":"2008","unstructured":"Verstrepen BE, Bins AD, Rollier CS, Mooij P, Koopman G, Sheppard NC et al. Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates. Vaccine 2008; 26: 3346\u20133351.","journal-title":"Vaccine"},{"key":"BFgt201487_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1479-0556-6-4","volume":"6","author":"D Pokorna","year":"2008","unstructured":"Pokorna D, Rubio I, Muller M . DNA-vaccination via tattooing induces stronger humoral and cellular immune responses than intramuscular delivery supported by molecular adjuvants. Genet Vaccines Ther 2008; 6: 4.","journal-title":"Genet Vaccines Ther"},{"key":"BFgt201487_CR34","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nmeth.1701","volume":"8","author":"TN Petersen","year":"2011","unstructured":"Petersen TN, Brunak S, von Heijne G, Nielsen H . SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 2011; 8: 785\u2013786.","journal-title":"Nat Methods"},{"key":"BFgt201487_CR35","doi-asserted-by":"publisher","first-page":"W526","DOI":"10.1093\/nar\/gki376","volume":"33","author":"A Grote","year":"2005","unstructured":"Grote A, Hiller K, Scheer M, Munch R, Nortemann B, Hempel DC et al. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res 2005; 33: W526\u2013W531.","journal-title":"Nucleic Acids Res"},{"key":"BFgt201487_CR36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1574-695X.2006.00177.x","volume":"49","author":"JW Hovius","year":"2007","unstructured":"Hovius JW, Li X, Ramamoorthi N, van Dam AP, Barthold SW, van der Poll T et al. Coinfection with Borrelia burgdorferi sensu stricto and Borrelia garinii alters the course of murine Lyme borreliosis. FEMS Immunol Med Microbiol 2007; 49: 224\u2013234.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"BFgt201487_CR37","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/gkp045","volume":"37","author":"JM Ruijter","year":"2009","unstructured":"Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den Hoff MJ et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 2009; 37: e45.","journal-title":"Nucleic Acids Res"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201487.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201487","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201487.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:06:22Z","timestamp":1689552382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,2]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["BFgt201487"],"URL":"https:\/\/doi.org\/10.1038\/gt.2014.87","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,2]]},"assertion":[{"value":"10 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}